Tectonic Therapeutic | AVRO - Pre Tax Profit



Tectonic Therapeutic reported $-19010000 in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
Alnylam Pharmaceuticals USD -35358000 6.24M Jun/2025
Celltrion KRW 195.49B 78.5B Mar/2025
Cspc Pharmaceutical CNY 833.21M 111.17M Dec/2024
Dianthus Therapeutics USD -31629000 3.19M Jun/2025
Divis Laboratories Ltd 7.33B 1.31B Jun/2025
Gilead Sciences USD 2.43B 780M Jun/2025
Ionis Pharmaceuticals USD 124M 271M Jun/2025
Kangmei Pharma -5720000 15.38M Sep/2024
Knight Therapeutics CAD -7144000 19.01M Mar/2024
Laboratorios Farma 26.78M 94.77M Jun/2025
MacroGenics USD -36150000 21.67M Jun/2025
Medical Developments International AUD -6390000 0 Dec/2023
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Organigram Holdings CAD -16200000 6.76M Jun/2025
Pfizer USD 3.04B 259M Jun/2025
Pharma Mar EUR 23.35M 27.26M Jun/2025
Qiagen NV USD 126.82M 7.27M Jun/2025
Roche Holding CHF 1.78B 2.33B Dec/2024
Sanofi EUR 1.42B 734M Jun/2025
Sarepta Therapeutics USD 153.64M 537.16M Jun/2025
Sartorius EUR 70.9M 28.6M Jun/2025
Takeda JPY 150.63B 257.93B Jun/2025
Tilray USD -83239000 49.47M Nov/2024
Zz Pientze Pharmaceu 523.11M 659.54M Jun/2025